Black Diamond Therapeutics, Inc. Common Stock (BDTX)
Since Aug 12, 2021, Black Diamond Therapeutics, Inc. Common Stock (BDTX) has reported earnings 21 times. On average the shares move ±5.44% post-earnings, with a positive reaction 52.4% of the time. Its largest post-earnings gain was +10.29% (May 12, 2025) and its largest decline was -22.64% (Dec 03, 2025). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How BDTX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.44%
Positive %
52.4%
Negative %
47.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 05, 2026 | ☽ POST | +7.87% | open_in_new |
| May 07, 2026 | ☀ PRE | -3.36% | open_in_new |
| Mar 16, 2026 | ☽ POST | +1.37% | open_in_new |
| Dec 03, 2025 | ☀ PRE | -22.64% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.44%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260805 | open_in_new SEC.gov |
| 8-K | 20260805 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260727 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260708 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
Frequently asked about BDTX earnings
When does Black Diamond Therapeutics, Inc. Common Stock report earnings next? expand_more
Black Diamond Therapeutics, Inc. Common Stock (BDTX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does BDTX stock move after earnings? expand_more
Over 21 reports, BDTX has moved an average of ±5.44% the session after earnings, closing higher 52.4% of the time.
What was BDTX's biggest post-earnings move? expand_more
BDTX's largest post-earnings gain on record was +10.29% on May 12, 2025, and its largest decline was -22.64% on Dec 03, 2025.
Where can I find Black Diamond Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Black Diamond Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right